Recall record at a glance
| Official record | H-1222-2026 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Ongoing |
| Recalling firm | FACTORY6, INC. |
| Report date | Aug 12, 2026 |
| Recall initiation date | Jul 19, 2026 |
| Quantity | 2,048 bottles |
| Location | Lindon, UT, United States |
Official product description
Zen Principle Naturals Moringa Leaf Powder dietary supplement, 900mg capsules, 180 capsules per PET white bottle. Intended Use: take 2 capsules per day. Route of Administration: OraI. Manufactured for Zen Principle 774 Mays Blvd Incline Village, NV 89451. The product is offered as a 1-pack (180 capsules; Amazon code/FNSKU X000ZJJ4FT) and as a 2-pack (twin pack, 360 capsules; Amazon code/FNSKU X00159YJXP).
Why the product was recalled
Possible Salmonella in Moringa Leaf Powder product.
Distribution information
Distributed to Nevada for further distribution.
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Press Release.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.